Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Cooper Cancer Center Looks to Expand Its Research, Geographic Reach

MD Anderson Cooper Cancer facilityCamden, NJ, July 27, 2016 ― Katie Jennings reports on Politico New Jersey that three years into a partnership with Houston-based MD Anderson Cancer Center, the president and CEO of Cooper University Health Care said the South Jersey health system is focused on expanding the geographic reach of its cancer services, as well as its research capabilities.

“We want to expand cancer care in our state, not just in our traditional local market,” Adrienne Kirby told POLITICO New Jersey.

Earlier this month, Cooper, located in Camden, opened a 30-bed inpatient unit to match the patient experience at the flagship outpatient facility which opened in 2013, Kirby said.

Cooper has satellite facilities in Voorhees and Willingboro and is eyeing future expansion at the Jersey Shore as it continues to draw New Jersey patients who otherwise may have gone to nearby Philadelphia-based medical centers, like Penn Medicine’s Abramson Cancer Center, Fox Chase Cancer Center and Jefferson’s Sidney Kimmel Cancer Center.

“We’ve been able to bend a curve that we were seeing in terms of out-migration,” said Christie Winn, senior vice president at Cooper.

Cooper saw a 20-percent combined increase in inpatient and outpatient volume for cancer treatment in the first year of the partnership, according to internal numbers, and has seen continued growth of 8 percent to 9 percent since, Winn said.

The MD Anderson-Cooper partnership is part of a growing nationwide trend as the world’s top cancer centers seek to form strategic alliances across state lines.

There has also been an increased push from the federal level regarding cancer research collaborations, since Vice President Joe Biden began outlining his cancer “moon shot” initiative earlier this year in the wake of his son’s death from brain cancer.

For Jennings’ full story, click here.

Follow Katie Jennings on Twitter @katiedjennings.